Alliance for Regenerative Medicine
18 FOLLOWERS
Latest News and Press Releases from The Alliance for Regenerative Medicine. The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization dedicated to furthering the cause of regenerative medicines and advanced therapies. ARM promotes legislative, regulatory, and manufacturing initiatives to advance this innovative sector.
Alliance for Regenerative Medicine
1M ago
The EU Health Technology Assessment (HTA) Coordination Group’s ‘Methodological Guideline for Quantitative Evidence Synthesis: Direct and Indirect Comparisons’ is discouraging news for rare disease patients and the Advanced Therapy Medicinal Products (ATMP) sector ..read more
Alliance for Regenerative Medicine
2M ago
The voluntary model recognizes that transformative, durable, and potentially curative gene therapies require innovative thinking about access, payment, and healthcare delivery ..read more
Alliance for Regenerative Medicine
7M ago
Alliance for Regenerative Medicine
7M ago
Alliance for Regenerative Medicine
9M ago
The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the engineered cell therapy and genetic medicines sector, announced the promotion of Michael Lehmicke to Senior Vice President, Science & Industry Affairs, effective immediately ..read more
Alliance for Regenerative Medicine
11M ago
Without changes recognizing the unique characteristics of ATMPs, the EU’s new Joint Clinical Assessment will fail to deliver the next generation of transformative therapies to rare disease patients, according to the Alliance for Regenerative Medicine, EveryLife Foundation for Rare Diseases, and Rare Diseases International ..read more
Alliance for Regenerative Medicine
1y ago
Alliance for Regenerative Medicine
1y ago
The European Union can reverse its declining competitiveness and ensure patient access to transformative treatments if it modernizes its policy and regulatory framework to reflect the distinct promise of cell and gene therapies as the future of medicine, the Alliance for Regenerative Medicine (ARM) will say during an event at the EU Parliament on 29 November ..read more
Alliance for Regenerative Medicine
1y ago
The European Commission’s proposed ‘Substances of Human Origin’ (SoHO) Regulation holds the promise of improving patient safety while establishing greater legal and regulatory certainty across the EU ..read more
Alliance for Regenerative Medicine
1y ago
The Alliance for Regenerative Medicine (ARM) and the National Institute for Innovation in Manufacturing BioPharmaceuticals (NIIMBL) today released Project A-Cell, a multistakeholder collaboration to incorporate Quality by Design (QbD) principles into a manufacturing case study of a Chimeric Antigen Receptor T-cell (CAR-T) therapy ..read more